Emergent BioSolutions Inc. ( EBS) - Key Metrics
EBS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.54 | -$3.49 | -$0.31 | -$0.35 |
| 2026Q1 | $3.01 | $0.13 | -$0.65 | -$0.70 |
| 2025Q4 | $2.84 | -$1.04 | $1.48 | $1.41 |
| 2025Q3 | $4.34 | $0.96 | -$0.04 | -$0.11 |
| 2025Q2 | $2.60 | -$0.22 | $1.96 | $1.91 |
EBS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.60 |
| 2026Q1 | 0% | 15.96 |
| 2025Q4 | 0% | -2.97 |
| 2025Q3 | 0% | 2.30 |
| 2025Q2 | 0% | -7.25 |
EBS
Price: $6.38
52 week price:
Earnings Per Share: -3.15 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 633400
Ebitda: 58.1 millionMarket Capitalization: 364.8 million